skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Recombinant Vaccinia-NY-ESO-1 Vaccine (Code C48419)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant Vaccinia-NY-ESO-1 Vaccine

Definition: A cancer vaccine consisting of a recombinant vaccinia viral vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with recombinant vaccinia NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. (NCI05)

Label: Recombinant Vaccinia-NY-ESO-1 Vaccine

NCI Thesaurus Code: C48419 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1541542  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Recombinant Vaccinia-NY-ESO-1 Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 428314
PDQ Open Trial Search ID 428314 (check for NCI PDQ open clinical trial info)
UMLS CUI C1541542

Other Properties:
     Name Value (qualifiers indented underneath)
code C48419
Legacy_Concept_Name Recombinant_Vaccinia-NY-ESO-1_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom